A prospective cohort study on the risk of lipodystrophy in HIV-1-infected patients treated with highly active antiretroviral therapy not containing protease inhibitors

被引：0
|
作者：
Martinez, E
Bailey, L
Milinkovic, A
Blanco, JL
Lonca, M
Laguno, M
Leon, A
Mallolas, J
Phillips, AN
Gatell, JM
机构：
[1] Hosp Clin Univ, Inst Infect & Immunol, Barcelona, Spain
[2] UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London, England
来源：
ANTIVIRAL THERAPY | 2003年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
120
引用
收藏
页码：L80 / L80
页数：1
相关论文
共 50 条
  • [1] Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors:: a prospective cohort study
    Martinez, E
    Mocroft, A
    García-Viejo, MA
    Pérez-Cuevas, JB
    Blanco, JL
    Mallolas, J
    Bianchi, L
    Conget, I
    Blanch, J
    Phillips, A
    Gatell, JM
    LANCET, 2001, 357 (9256): : 592 - 598
  • [2] Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy
    Koppel, K
    Bratt, G
    Schulman, S
    Bylund, H
    Sandström, E
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (05) : 441 - 449
  • [3] Hyperglycosylated ferritin in sera of HIV-1-infected patients treated with highly active antiretroviral therapy
    Malvoisin, E
    Livrozet, JM
    Ducluzeau, PH
    Makloufi, D
    Cohen, R
    Vincent, N
    AIDS, 2006, 20 (03) : 457 - 459
  • [4] Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study
    Hung, CC
    Hsiao, CF
    Wang, JL
    Chen, MY
    Hsieh, ZM
    Sheng, WH
    Chang, SC
    INTERNATIONAL JOURNAL OF STD & AIDS, 2005, 16 (10) : 673 - 676
  • [5] A prospective cohort study on the risk for lipodystrophy in HIV-infected patients treated with protease inhibitor-containing regimens.
    Martínez, E
    Mocroft, A
    García-Viejo, MA
    Pérez-Cuevas, JB
    Bianco, JL
    Mallolas, J
    Bianchi, L
    Conget, I
    Gatell, JM
    AIDS, 2000, 14 : S55 - S55
  • [6] Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients
    Foudraine, NA
    Hovenkamp, E
    Notermans, DW
    Meenhorst, PL
    Klein, MR
    Lange, JMA
    Miedema, F
    Reiss, P
    AIDS, 1999, 13 (02) : 177 - 184
  • [7] Effect of protease inhibitors on apolipoprotein B levels and plasma lipid profile in HIV-1-infected patients on highly active antiretroviral therapy
    Domingo, P
    Sambeat, MA
    Pérez, A
    Ordoñez, J
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (01) : 114 - 116
  • [8] Skeletal Muscle Toxicity in HIV-1-Infected Patients Treated with a Raltegravir-Containing Antiretroviral Therapy: A Cohort Study
    Calza, Leonardo
    Danese, Ilaria
    Colangeli, Vincenzo
    Vandi, Giacomo
    Manfredi, Roberto
    Girometti, Nicolo
    Borderi, Marco
    Appolloni, Lucia
    Puggioli, Cristina
    Viale, Pierluigi
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 (12) : 1162 - 1169
  • [9] Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients
    Larussa, Dora
    Lorenzini, Patrizia
    Cingolani, Antonella
    Bossolasco, Simona
    Grisetti, Susanna
    Bongiovanni, Marco
    Moretti, Francesca
    Uccella, Ilaria
    Zannoni, Paolo
    Foresti, Sergio
    Mazzarello, Giovanni
    Arcidiacono, Maria Irene
    Pedale, Rosa
    Ammassari, Adriana
    Tozzi, Valerio
    Perno, Carlo Federico
    Monforte, Antonella D'Arminio
    Cinque, Paola
    Antinori, Andrea
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (05) : 386 - 392
  • [10] Behcet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy
    Gomez-Puerta, Jose A.
    Espinosa, Gerard
    Miro, Jose M.
    Sued, Omar
    Llibre, Josep M.
    Cervera, Ricard
    Font, Josep
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2006, 8 (07): : 513 - 514
12345